No results for ‘’
Alembic Ltd
₹89.98
(4.04%)
Fri, 26 Jun 2026, 08:55 pm
Health Technology
Pharmaceuticals: Major
24.5KAlembic Ratios
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 12.36 | 11.07 | 7.02 | 40.19 | 16.79 | 0 | 0 | 18.20 | 16 | 38.50 | 4.02 | 6.74 | 8.74 | 5.11 | 2.79 | 7.70 | 8.37 | 7.99 | 8 | 8.14 |
| Price to book ratio | 2.89 | 2.03 | 2.31 | 1.30 | 1.95 | 4.66 | 1.09 | 1.02 | 2.06 | 3.50 | 1.17 | 1.07 | 1.31 | 0.90 | 0.65 | 1.15 | 0.74 | 0.73 | 0.98 | 1.08 |
| Price to sales ratio | 1.53 | 1.12 | 0.79 | 0.39 | 0.59 | 4.88 | 1.91 | 1.21 | 3.33 | 6.94 | 7.40 | 6.98 | 11.37 | 8.82 | 12.41 | 35.94 | 23.76 | 11.97 | 13.65 | 11.40 |
| Price to cash flow ratio | 20.58 | 9.75 | 34.42 | 5.13 | 5.64 | 89.56 | 0 | 2.64 | 220.60 | 23.30 | 29.54 | 12.61 | 29.60 | 24.02 | 9.75 | 0 | 30.17 | 15.80 | 30.90 | 16.99 |
| Enterprise value | 1150Cr | 965Cr | 1192Cr | 893Cr | 1049Cr | 1042Cr | 346Cr | 233Cr | 495Cr | 910Cr | 894Cr | 872Cr | 1301Cr | 1045Cr | 804Cr | 2618Cr | 1830Cr | 1475Cr | 2144Cr | 2484Cr |
| Enterprise value to EBITDA ratio | 11.15 | 8.49 | 8.58 | 7.53 | 10.11 | 1440 | 0 | 25.50 | 28.09 | 2100 | 143.85 | 125.75 | 116.22 | 57.68 | 229.85 | 231.62 | 129.55 | 36.46 | 37.57 | 26.36 |
| Debt to equity ratio | 0.54 | 0.87 | 1.24 | 1.43 | 1.21 | 0.32 | 0.68 | 0.12 | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Return on equity % | 25.75 | 19.60 | 30.89 | 3.22 | 11.83 | -4.72 | -6 | 5.70 | 13.53 | 9.76 | 43.94 | 16.96 | 16.32 | 18.58 | 25.06 | 18.46 | 9.26 | 8.34 | 12.60 | 13.73 |
Alembic Ltd Ratios
The Alembic Ltd Ratios page provides a complete fundamental analysis of Alembic Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Alembic Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Alembic Ltd (NSE: ALEMBICLTD, BSE: 506235) is currently trading at ₹89.98, with a market capitalization of ₹2408.1Cr. As a major player in the Health technology sector and Pharmaceuticals: major industry, Alembic Ltd remains a key stock for fundamental analysis using Alembic Ltd Ratios.
Alembic Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Alembic Ltd P/E ratio currently stands at 8.14, making it one of the most tracked metrics in Alembic Ltd Ratios.
Historically, the Alembic Ltd P/E ratio has shown strong fluctuations:
- 2024: 8.14
- 2023: 8
- 2022: 7.99
- 2021: 8.37
- 2020: 7.70
The rising Alembic Ltd P/E ratio indicates increasing investor confidence and premium valuation.
Price to Book Ratio (P/B)
The Alembic Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.08.
Historical P/B trend:
- 2024: 1.08
- 2023: 0.98
- 2022: 0.73
- 2021: 0.74
Alembic Ltd shows reasonable valuation compared to its asset base.
Price to Sales Ratio (P/S)
The Alembic Ltd P/S ratio currently stands at 11.40, an important part of Alembic Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 11.40
- 2023: 13.65
- 2022: 11.97
- 2021: 23.76
A stable or declining Alembic Ltd P/S ratio indicates cautious market sentiment.
Alembic Ltd Price to Cash Flow Ratio (P/CF)
The Alembic Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 16.99.
Historical Alembic Ltd Price to Cash Flow Ratio:
- 2024: 16.99
- 2023: 30.90
- 2022: 15.80
- 2021: 30.17
- 2020: 0
The declining Alembic Ltd Price to Cash Flow Ratio suggests improving cash flow strength.
Alembic Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Alembic Ltd EV currently stands at ₹2484Cr, representing the total company valuation including debt.
Historical EV trend:
- 2024: 2484Cr
- 2023: 2144Cr
- 2022: 1475Cr
- 2021: 1830Cr
Alembic Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.
EV/EBITDA Ratio
The Alembic Ltd EV/EBITDA ratio is currently 26.36, a key metric in Alembic Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 26.36
- 2023: 37.57
- 2022: 36.46
- 2021: 129.55
Stable Alembic Ltd EV/EBITDA indicates balanced valuation.
Alembic Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Alembic Ltd D/E ratio is currently 0.01, reflecting leverage and financial stability.
Historical D/E:
- 2024: 0.01
- 2023: 0
- 2022: 0
- 2021: 0
Alembic Ltd maintains a strong balance sheet with low debt levels.
Return on Equity (ROE %)
The Alembic Ltd ROE currently stands at 13.73%, showing profitability and capital efficiency.
Historical ROE:
- 2024: 13.73
- 2023: 12.60
- 2022: 8.34
- 2021: 9.26
Alembic Ltd maintains stable profitability levels.
Alembic Ltd Ratios Analysis Summary
The Alembic Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Alembic Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Alembic Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.